PEOPLE
Jie Shen is Professor of Neurology at Harvard Medical School. She received her Ph.D. in molecular biology from the University of Virginia in 1995 studying the mechanisms of alternative splicing in Drosophila. As a postdoctoral fellow at MIT, she began the investigation of the molecular basis of Alzheimer’s disease using mouse genetic approaches. Since 1998, she has directed a molecular neurobiology laboratory whose major research interests focus on the pathogenesis of Alzheimer’s and Parkinson’s diseases. Her genetic studies have led to the proposal of the Presenilin Hypothesis, which posits that loss of presenilin function underlies neurodegeneration and dementia in the pathogenesis of Alzheimer’s disease. Her genetic analysis of gene products involved in Alzheimer’s and Parkinson’s diseases unexpectedly revealed that presynaptic defects in neurotransmitter release might underlie age-related neurodegeneration in these neurological disorders. Jie was the Director of the Udall Center of Excellence for Parkinson’s Disease at Brigham and Women’s Hospital, which focused on the role of LRRK2 and alpha-synuclein on the pathogenesis of Parkinson’s disease.
Email: jshen@bwh.harvard.edu
Dr. Jongkyun Kang is an Assistant Professor in the Department of Neurology, Harvard Medical School. He received his Ph.D. in Biological Sciences from Korea Advanced Institute of Science and Technology (KAIST) in South Korea, where he helped elucidate temperature perception and preference in mammals. Jongkyun then joined the Shen Lab as a Postdoctoral Fellow, where he developed novel Drosophila genetic models that demonstrated age-dependent neurodegeneration, and his genetic studies identified novel therapeutic targets for Alzheimer’s Disease. Jongkyun has expanded his expertise into mouse genetics, and he is investigating the molecular mechanisms of neuronal survival during aging using conditional APP and Presenilin mouse models.
Postdoctoral Fellows
Dr. Michael Hobin entered the Shen lab as a postdoctoral researcher in early 2022. His research project investigates the role of Presenilins in microglia and the pathogenesis of Alzheimer’s disease. He received his PhD in neuroscience from Brandeis University where he studied the role of post-transcriptional regulation in sleep behavior in a Drosophila model.
Dr. Anu Shahapal received her Ph.D. in Biomedical Sciences from Korea University where she characterized the function of the neuropeptide FAM19A5 in the central nervous system using LacZ knock-in mouse models. Anu joined the Shen Lab in early 2022 as a postdoctoral fellow. Her research focuses on the elucidation of the pathogenic mechanism of Parkinson’s disease. She is investigating the molecular and cellular mechanisms underlying degeneration of specific neuronal populations in Parkinson’s disease.
Dr. Chen Zhang received his Ph.D. in the School of Life Sciences of Gwangju Institute of Science and Technology (GIST) in South Korea. His Ph.D. research focused on the neuropeptide regulated reproduction (mating, oogenesis, and egg-laying) of Drosophila melanogaster. Chen joined the Shen Lab in 2022 as a postdoctoral fellow. His current research goal is to use Drosophila genetic model to identify downstream target genes of Presenilin, which has an important role in Alzheimer’s disease.
Research Assistants
Sofia Leone joined the lab in June 2022 after graduating from Villanova University with a B.S. in Cognitive & Behavioral Neuroscience. Sofia is excited to grow as a scientist, and to further foster her passion for neuroscience and neurodegenerative disease research.
Email: sleone3@bwh.harvard.edu
Program Manager
Kayla Edmunds joined the lab in December 2023 after working at St. Lawrence University as a Project Manager, where she graduated from with a B.S. in Conservation Biology in 2021. Kayla is excited to be a part of the Shen Lab and support Dr. Shen and the lab members in their varied research on neurodegenerative diseases.
Email: kmedmunds@bwh.harvard.edu